Risultati della ricerca - Balslev, Eva

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a... di Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Nielsen, Dorte

Testo Testo Testo

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery di Stovgaard, Elisabeth Specht, Tvedskov, Tove Filtenborg, Lænkholm, Anne Vibeke, Balslev, Eva

Testo Testo Testo

Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing di Poulsen, Tim S., Espersen, Maiken L. M., Kofoed, Vibeke, Dabetic, Tanja, Høgdall, Estrid, Balslev, Eva

Testo Testo Testo

Aberrations of ERBB2 and TOP2A genes in breast cancer di Nielsen, Kirsten Vang, Müller, Sven, Møller, Susanne, Schønau, Andreas, Balslev, Eva, Knoop, Ann S., Ejlertsen, Bent

Testo Testo Testo

Fibrolipomatous hamartoma in the median nerve in the arm - an unusual location but with MR imaging characteristics: a case report di Nilsson, Jessica, Sandberg, Kristina, Dahlin, Lars B, Vendel, Nina, Balslev, Eva, Larsen, Lone, Nielsen, Niels Søe

Testo Testo Testo

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine di Jørgensen, Charlotte LT, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Nielsen, Dorte L, Nielsen, Kirsten V

Testo Testo Testo

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase... di Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Ejlertsen, Bent, Jakobsen, Erik Hugger, Nielsen, Dorte Lisbet

Testo Testo Testo

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? di Munro, Alison F, Bartels, Annette, Balslev, Eva, Twelves, Christopher J, Cameron, David A, Brünner, Nils, Bartlett, John MS

Testo Testo Testo

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status di Nielsen, Kirsten Vang, Ejlertsen, Bent, Møller, Susanne, Jensen, Maj-Britt, Balslev, Eva, Müller, Sven, Knoop, Ann, Mouridsen, Henning T.

Testo Testo Testo

Breast cancer mortality in synchronous bilateral breast cancer patients di Mejdahl, Mathias Kvist, Wohlfahrt, Jan, Holm, Marianne, Balslev, Eva, Knoop, Ann Søegaard, Tjønneland, Anne, Melbye, Mads, Kroman, Niels

Testo Testo Testo

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer di Nielsen, Boye Schnack, Balslev, Eva, Poulsen, Tim Svenstrup, Nielsen, Dorte, Møller, Trine, Mortensen, Christiane Ehlers, Holmstrøm, Kim, Høgdall, Estrid

Testo Testo Testo

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing di Nygaard, Sanne, Jacobsen, Anders, Lindow, Morten, Eriksen, Jens, Balslev, Eva, Flyger, Henrik, Tolstrup, Niels, Møller, Søren, Krogh, Anders, Litman, Thomas

Testo Testo Testo

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group di Jørgensen, Charlotte Levin Tykjær, Bjerre, Christina, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Bartels, Annette, Brünner, Nils, Nielsen, Dorte L

Testo Testo Testo

Evidence of No Association Between Human Papillomavirus and Breast Cancer di Bønløkke, Sara, Blaakær, Jan, Steiniche, Torben, Høgdall, Estrid, Jensen, Steffen Grann, Hammer, Anne, Balslev, Eva, Strube, Mikael Lenz, Knakkergaard, Helle, Lenz, Suzan

Testo Testo Testo

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine di Stovgaard, Elisabeth S, Asleh, Karama, Riaz, Nazia, Leung, Samuel, Gao, Dongxia, Nielsen, Lise B, Lænkholm, Anne-Vibeke, Balslev, Eva, Jensen, Maj-Britt, Nielsen, Dorte, Nielsen, TO

Testo Testo Testo

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients di Jensen, Maj-Britt, Lænkholm, Anne-Vibeke, Balslev, Eva, Buckingham, Wesley, Ferree, Sean, Glavicic, Vesna, Dupont Jensen, Jeanette, Søegaard Knoop, Ann, Mouridsen, Henning T., Nielsen, Dorte, Nielsen, Torsten O., Ejlertsen, Bent

Testo Testo Testo

Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers di Thagaard, Jeppe, Stovgaard, Elisabeth Specht, Vognsen, Line Grove, Hauberg, Søren, Dahl, Anders, Ebstrup, Thomas, Doré, Johan, Vincentz, Rikke Egede, Jepsen, Rikke Karlin, Roslind, Anne, Kümler, Iben, Nielsen, Dorte, Balslev, Eva

Testo Testo Testo

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded... di Buhl, Anna Sofie Kappel, Christensen, Troels Dreier, Christensen, Ib Jarle, Nelausen, Knud Mejer, Balslev, Eva, Knoop, Ann Søegaard, Brix, Eva Harder, Svensson, Else, Glavicic, Vesna, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Søren, Jakobsen, Erik Hugger, Bogovic, Jurij, Ejlertsen, Bent, Rasmussen, Annie, Hansen, Anker, Knudsen, Steen, Nielsen, Dorte, Jensen, Peter Buhl

Testo Testo Testo

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study di Groen, Emma J., Hudecek, Jan, Mulder, Lennart, van Seijen, Maartje, Almekinders, Mathilde M., Alexov, Stoyan, Kovács, Anikó, Ryska, Ales, Varga, Zsuzsanna, Andreu Navarro, Francisco-Javier, Bianchi, Simonetta, Vreuls, Willem, Balslev, Eva, Boot, Max V., Kulka, Janina, Chmielik, Ewa, Barbé, Ellis, de Rooij, Mathilda J., Vos, Winand, Farkas, Andrea, Leeuwis-Fedorovich, Natalja E., Regitnig, Peter, Westenend, Pieter J., Kooreman, Loes F. S., Quinn, Cecily, Floris, Giuseppe, Cserni, Gábor, van Diest, Paul J., Lips, Esther H., Schaapveld, Michael, Wesseling, Jelle

Testo Testo Testo

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group di Amgad, Mohamed, Stovgaard, Elisabeth Specht, Balslev, Eva, Thagaard, Jeppe, Chen, Weijie, Dudgeon, Sarah, Sharma, Ashish, Kerner, Jennifer K., Denkert, Carsten, Yuan, Yinyin, AbdulJabbar, Khalid, Wienert, Stephan, Savas, Peter, Voorwerk, Leonie, Beck, Andrew H., Madabhushi, Anant, Hartman, Johan, Sebastian, Manu M., Horlings, Hugo M., Hudeček, Jan, Ciompi, Francesco, Moore, David A., Singh, Rajendra, Roblin, Elvire, Balancin, Marcelo Luiz, Mathieu, Marie-Christine, Lennerz, Jochen K., Kirtani, Pawan, Chen, I-Chun, Braybrooke, Jeremy P., Pruneri, Giancarlo, Demaria, Sandra, Adams, Sylvia, Schnitt, Stuart J., Lakhani, Sunil R., Rojo, Federico, Comerma, Laura, Badve, Sunil S., Khojasteh, Mehrnoush, Symmans, W. Fraser, Sotiriou, Christos, Gonzalez-Ericsson, Paula, Pogue-Geile, Katherine L., Kim, Rim S., Rimm, David L., Viale, Giuseppe, Hewitt, Stephen M., Bartlett, John M. S., Penault-Llorca, Frédérique, Goel, Shom, Lien, Huang-Chun, Loibl, Sibylle, Kos, Zuzana, Loi, Sherene, Hanna, Matthew G., Michiels, Stefan, Kok, Marleen, Nielsen, Torsten O., Lazar, Alexander J., Bago-Horvath, Zsuzsanna, Kooreman, Loes F. S., van der Laak, Jeroen A. W. M., Saltz, Joel, Gallas, Brandon D., Kurkure, Uday, Barnes, Michael, Salgado, Roberto, Cooper, Lee A. D.

Testo Testo Testo